JE MEDICAL ASSOCIATES LTD.Active

Company number 11409392Private limited companyIncorporated 2018

Key figures

£11,350+756.0%
Net assets 2024/25
+72.2%
Average annual growth 2019/20–2024/25
-40 k-20 k020 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, JE MEDICAL ASSOCIATES LTD. does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 k40 k60 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Turnover7,301————
Profit for the year-30,727————
Cash at bank and in hand————5,104
Total assets75413,38923,71021,64223,879
Total liabilities39,93031,21529,96622,96835,229
Net assets / total equity-34,176-12,8266,2561,32611,350
Average number of employees00111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: JE MEDICAL ASSOCIATES LTD.

Company

JE MEDICAL ASSOCIATES LTD. is a private limited company registered with Companies House under company number 11409392. It was incorporated on 11 Jun 2018. Its status is active. The registered office is in Bexley (DA5). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files abridged accounts (unaudited). Net assets were £11,350, up 756% on the previous year. Cash at bank and in hand was £5,104. Total assets were £23,879 and total liabilities £35,229. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 9 Jul 2027.